BioScience Health Innovations Gross Margin Growth & History (BHIC)

BioScience Health Innovations's gross margin was 56.97% for fiscal 2025.

View full BioScience Health Innovations company overview

BioScience Health Innovations annual gross margin history

BioScience Health Innovations annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3156.97%−13.98 pp
20242024-12-3170.94%−10.12 pp
20232023-12-3181.06%−4.95 pp
2022 · Dec 312022-12-3186.01%—

BioScience Health Innovations gross margin trends

Between the periods ended 2022-12-31 and 2025-12-31, BioScience Health Innovations's gross margin decreased from 86.01% to 56.97%, a change of −29.05 percentage points. The latest reported quarter, Q2 2026, shows 63.63%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioScience Health Innovations source filings ↗

Community posts

It’s quiet here.

No posts about BHIC yet. Start the conversation.

Write the first post